Episurf Medical AB

Episurf Medical AB is a Swedish medical device company focused on developing and manufacturing patient-specific solutions for repairing local cartilage damage in joints, particularly the knee. Founded by Professor Leif Ryd, the company addresses the needs of middle-aged individuals with aging joints who have limited surgical options. Their product range includes customized implants and surgical instruments created using advanced 3D imaging technology. Key offerings in their knee portfolio are the Episealer Condyle Solo, Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, Epioscopy, and the Episealer Patellofemoral System. These products are designed to enhance surgical outcomes through minimally invasive procedures and personalized treatment options. Episurf Medical operates from its headquarters in Stockholm, Sweden, and has sales representation in the United States, Europe, and Asia. The company is publicly traded on Nasdaq Stockholm under the ticker EPIS B. Their primary customers are orthopedic surgeons who treat middle-aged patients with localized cartilage damage, providing tailored surgical solutions to improve patient care.

• Employees 27
• Founded 2009
• Annual Revenue $1183000
• Total Funding $18425400